Local providers are following instructions from CDPHE and CDC to temporarily pause use of Johnson & Johnson (Janssen) vaccine.
More than 6.8 million doses of the Janssen vaccine have been administered in the United States. The Centers for Disease Control and the Federal Drug Administration announced that there have been 6 instances of an uncommon type of blood clot in people who received the Janssen vaccine. This type of blood clot requires a specific kind of treatment, and part of the reason for pausing the use of this vaccine is to make sure that healthcare providers understand how to recognize and treat these potential but rare occurrences.
Anyone who received the Johnson & Johnson (Janssen) vaccine within the last three weeks and who develops severe headache, abdominal pain, leg pain, or shortness of breath should contact their health care provider. Individuals who received the Johnson & Johnson (Janssen) vaccine more than a month ago are at very low risk of serious side effects.
